Pillsbury Winthrop Shaw Pittman LLP advised Alume Biosciences on the deal. Alume Biosciences, a leader in the field of nerve-targeted diagnostics and therapeutics, announced a $13 million...
This content is for Standard 1 Year members only. LoginJoin Now